Eight patients with mild or moderate forms of the brain-destroying disorder took part in the small trial. Seven of the patients showed a ‘highly significant improvement’ in tests of their memory, language, attention, behaviour and moods. The patients even didn’t want to give the equipment back. TEMT is about wearing a skullcap of magnets which sent electric pulses to break down build-ups of proteins known to stop nerve cells working properly. During the tests patients used the TEMT headsets twice a day for an hour at a time. TEMT works by breaking up toxic clumps of proteins called amyloid-beta and tau, which is thought to be the cause of Alzheimer’s.
At this time is not known if TEMT will have capability to reverse disease. None of the patients suffered any damaging side effects from the treatment. Alzheimer’s patients can usually expect to see their score worsen by about four points a year on a scale of 0-70, the researchers said. ‘We were particularly surprised that this highly significant improvement in the ADAS-cog was maintained even two weeks after treatment was completed,’ said Dr Gary Arendash, the company’s chief executive officer. On the other part, more than 150 trials of medications against Alzheimer’s disease have failed since 1998. Billions of dollars have been invested.